NEW YORK (GenomeWeb News) - In a report released yesterday that broadly sketches personalized medicine as an essential component of the future of medicine, US Department of Health and Human Services Secretary Michael Leavitt stressed the need for continued research in genomics and bioinformatics, enhanced collaboration and information sharing, and the value of patients’ rights in individualized medicine as necessary foundations for any advances to come.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.